Fingerprint
Dive into the research topics of 'Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks
S. R. Alberts, C. Erlichman, J. Sloan, S. H. Okuno, P. A. Burch, J. Rubin, H. C. Pitot, R. M. Goldherg, A. A. Adjei, P. J. Atherton, S. H. Kaufmann
Research output: Contribution to journal › Article › peer-review
7
Scopus
citations